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Leber hereditary optic neuropathy (LHON), acute or subacute vision
loss due to retinal ganglion cell deathwhich in the long run leads to optic
nerve atrophy is one of the most widely studied maternally inherited
diseases caused by mutations in mitochondrial DNA. Although three
commonmutations, 11778G>A,14484T>C or 3460G>A are responsible
for over 90% of cases and affect genes encoding complex I subunits of the
respiratory chain, their influence on bioenergetic properties of the cell is
marginal and cannot fully explain the pathology of the disease. The
following chain of events was proposed, based on biochemical and
anatomical properties of retinal ganglion cells whose axons form the
optic nerve: mitochondrial DNA mutations increase reactive oxygen
species production in these sensitive cells, leading to caspase indepen-
dent apoptosis. As LHON is characterized by lowpenetrance and sex bias
(men are affected about 5 times more frequently than women) the
participation of theother factors— genetic and environmental—besides
mtDNA mutations was studied. Mitochondrial haplogroups and smok-
ing are some of the factors involved in the complex etiology of this
disease. The results of mutation and haplogroup distribution in Polish
LHON patients is presented as well as molecular study of lymphoblasts
with two mtDNA mutations 3460G>A and 11778G>A.
doi:10.1016/j.bbabio.2010.04.156
4L.2 Defects in mitochondrial oxidative phosphorylation: Role
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Mitochondrial dysfunction is amajor contributor in heart failure (HF).
Inmoderately severe coronarymicroembolization-inducedHF indogswe
reported adecrease in oxidative phosphorylation in cardiacmitochondria
due to the decrease in the amount of the supercomplex consisting of
complex I/complex III dimer/complex IV. We concluded that the
mitochondrial defect in HF lies in the organization of respirasomes. We
asked whether this defect in the supramolecular assembly is due to
changes in the phospholipids of the mitochondrial inner membrane or
modifications of the subunits of the electron transport chain complexes.
The contents of the main phospholipid species, including cardiolipin, as
well as the molecular species of cardiolipin, were unchanged in cardiac
mitochondria in HF. In heart mitochondria isolated from HF complex IV
not incorporated into the respirasomes contained an increased content of
threonine phosphorylation. This suggested that cyclic AMP may have a
role. In saponin-permeabilized heart muscle fibers, cAMP caused a
decrease in oxidative phosphorylation, at least at the level of complex IV.
We suggest that phosphorylation of specific complex IV subunits either
limits the incorporation of complex IV in supercomplexes or decreases
supercomplex stability.
doi:10.1016/j.bbabio.2010.04.157
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Mitochondrial diseases due to inborn defects of ATP synthase result
from mutations in both mitochondrial and nuclear genes. Maternally
transmitted dysfunction of ATP synthase is mainly caused by mtDNA
missensemutations of varying pathogenicity in the ATP6 gene. They alter
the function of FO proton channel, result in loss of ATP-synthetic activity
and manifest as NARP, MILS or striatal necrosis syndromes. Rarely also
ATP8 mutation or altered splicing of ATP8–ATP6 transcript is found. A
distinct groupof inborndefects is representedbyATP synthasedeficiency
due to nuclear genome mutations. Biochemically, it is characterized by
selective inhibition of enzyme biogenesis and patients show generalized
≥70% decrease in the content of ATP synthase. Insufficient ATP synthase
phosphorylating capacity results in impaired energy provision and
increased ROS production due to elevated level of mitochondrial
membrane potential. ATP synthase deficiency appears to be rather
frequent, most cases present with neonatal onset, hypotonia, lactic
acidosis, hyperammonemia, cardiomyopathy and 3-methylglutaconic
aciduria; about half of them die within few months or years. Up to now
pathogenic mutations have been found in two genes, both coding for
ancillary factors of ATP synthase biogenesis. The first genetic defect was
described in ATPAF2 gene for assembly factor of F1 subunit a, in a case
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